Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shai Yarkoni

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Immunologic Research|December 28, 2013
Lymphopenia is detrimental to therapeutic approaches to type 1 diabetes using regulatory T cellsShifra Ash, Shai Yarkoni, Nadir Askenasy
Autoimmunity Reviews|May 20, 2008
Mechanisms of T regulatory cell functionNadir Askenasy, Ayelet Kaminitz, Shai Yarkoni
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 19, 2003
Halofuginone to treat fibrosis in chronic graft-versus-host disease and sclerodermaMark Pines, David Snyder, Shai Yarkoni, et al.
Frontiers in Immunology|June 7, 2014
Antigen-Specific Priming is Dispensable in Depletion of Apoptosis-Sensitive T Cells for GvHD ProphylaxisShai Yarkoni, Jerry Stein, Isaac Yaniv, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 10, 2012
IL-2-targeted therapy ameliorates the severity of graft-versus-host disease: ex vivo selective depletion of host-reactive T cells and in vivo therapyShai Yarkoni, Tatyana B Prigozhina, Shimon Slavin, et al.
Bioessays : News and Reviews in Molecular, Cellular and Developmental Biology|August 12, 2008
Involvement of IL-2 in homeostasis of regulatory T cells: the IL-2 cycleShai Yarkoni, Ayelet Kaminitz, Yuval Sagiv, et al.
Annals of the New York Academy of Sciences|September 18, 2009
A fusion protein composed of IL-2 and caspase-3 ameliorates the outcome of experimental inflammatory colitisYuval Sagiv, Ayelet Kaminitz, Haya Lorberboum-Galski, et al.
European Journal of Immunology|September 8, 2009
Targeted therapy to the IL-2R using diphtheria toxin and caspase-3 fusion proteins modulates Treg and ameliorates inflammatory colitisShai Yarkoni, Yuval Sagiv, Ayelet Kaminitz, et al.
Gynecologic Oncology|December 7, 2002
Cytokeratin 20 as a biomarker of gestational trophoblastic disease: diagnostic and prognostic significanceRodica Stackievicz, Liat Drucker, Ruth Zemer, et al.
Journal of Investigative Medicine : the Official Publication of the American Federation for Clinical Research|November 24, 2004
Simvastatin induces death of multiple myeloma cell linesNaomi Gronich, Liat Drucker, Hava Shapiro, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Immunologic Research|December 28, 2013
Lymphopenia is detrimental to therapeutic approaches to type 1 diabetes using regulatory T cellsShifra Ash, Shai Yarkoni, Nadir Askenasy
Autoimmunity Reviews|May 20, 2008
Mechanisms of T regulatory cell functionNadir Askenasy, Ayelet Kaminitz, Shai Yarkoni
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 19, 2003
Halofuginone to treat fibrosis in chronic graft-versus-host disease and sclerodermaMark Pines, David Snyder, Shai Yarkoni, et al.
Frontiers in Immunology|June 7, 2014
Antigen-Specific Priming is Dispensable in Depletion of Apoptosis-Sensitive T Cells for GvHD ProphylaxisShai Yarkoni, Jerry Stein, Isaac Yaniv, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 10, 2012
IL-2-targeted therapy ameliorates the severity of graft-versus-host disease: ex vivo selective depletion of host-reactive T cells and in vivo therapyShai Yarkoni, Tatyana B Prigozhina, Shimon Slavin, et al.
Bioessays : News and Reviews in Molecular, Cellular and Developmental Biology|August 12, 2008
Involvement of IL-2 in homeostasis of regulatory T cells: the IL-2 cycleShai Yarkoni, Ayelet Kaminitz, Yuval Sagiv, et al.
Annals of the New York Academy of Sciences|September 18, 2009
A fusion protein composed of IL-2 and caspase-3 ameliorates the outcome of experimental inflammatory colitisYuval Sagiv, Ayelet Kaminitz, Haya Lorberboum-Galski, et al.
European Journal of Immunology|September 8, 2009
Targeted therapy to the IL-2R using diphtheria toxin and caspase-3 fusion proteins modulates Treg and ameliorates inflammatory colitisShai Yarkoni, Yuval Sagiv, Ayelet Kaminitz, et al.
Gynecologic Oncology|December 7, 2002
Cytokeratin 20 as a biomarker of gestational trophoblastic disease: diagnostic and prognostic significanceRodica Stackievicz, Liat Drucker, Ruth Zemer, et al.
Journal of Investigative Medicine : the Official Publication of the American Federation for Clinical Research|November 24, 2004
Simvastatin induces death of multiple myeloma cell linesNaomi Gronich, Liat Drucker, Hava Shapiro, et al.
Pageof 2